Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.22 USD | +1.76% | +8.21% | -3.51% |
May. 10 | HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating | MT |
May. 09 | Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.